VEGFA Antikörper (AA 27-130) (FITC)
Kurzübersicht für VEGFA Antikörper (AA 27-130) (FITC) (ABIN7667283)
Target
Alle VEGFA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 27-130
-
Verwendungszweck
- FITC conjugated mouse monoclonal antibody raised against a partial recombinant VEGF.
-
Sequenz
- APMAEGGGQN HHEVVKFMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDEGLECVP TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCEC
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- VEGF (NP_003367, 27 a.a. ~ 130 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Isotyp
- IgG2a kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 4°C.
-
-
- VEGFA (Vascular Endothelial Growth Factor A (VEGFA))
-
Andere Bezeichnung
- VEGFA
-
Hintergrund
-
gene_description: vascular endothelial growth factor A
gene_alias: MGC70609|VEGF|VEGF-A|VPF
-
Gen-ID
- 7422
-
NCBI Accession
- NM_003376
-
Pathways
- RTK Signalweg, Glycosaminoglycan Metabolic Process, Regulation of Cell Size, Tube Formation, Signaling Events mediated by VEGFR1 and VEGFR2, Platelet-derived growth Factor Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Target
-